Francisco Rivera

Dr. Francisco Rivera

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2026 in Diabetology
Verified
Journal Article
Open access
PDF file
NSNatalia Sanchez
Natalia Sanchez
SLSantiago de Loredo
Santiago de Loredo
MRMaria Fernanda Recanatesi
Maria Fernanda Recanatesi
Silvia Beatriz Gorban de LapertosaSilvia Beatriz Gorban de Lapertosa
Silvia Beatriz Gorban de Lapertosa
DCDaniel O. Croatto
Daniel O. Croatto
CGClaudio Daniel Gonzalez
Claudio Daniel Gonzalez
Background and Objectives: The objectives of this study were to determine the prevalence of diabetes mellitus (DM) and major cardiometabolic comorbidities in adults living in El Trébol, Argentina, and to evaluate their associations using laboratory-confirmed, community-based data. Methods: A cross-sectional, probabilistic, two-phase design was implemented, combining a household survey with clinical and biochemical assessments. Of 1112 surveyed adults aged 20–79 years, 860 completed the clinical phase and formed the effective sample. Cardiometabolic risk factors, including obesity, hypertension, dyslipidemia, and physical inactivity, were assessed through standardized measurements and questionnaires. Multivariate logistic regression explored independent associations with DM. Results: Crude DM prevalence was 10.47%, higher in men and increasing markedly with age; the age-standardized prevalence for the Argentine population was 9.87%. Of all diabetes cases, 23% were previously undiagnosed. Obesity (35.62%), hypertension (38.83%), dyslipidemia, and physical inactivity (83.84%) were highly prevalent. DM was independently associated with older age, higher BMI, elevated triglycerides, lower HDL cholesterol, and insufficient physical activity. Conclusions: This study reveals a substantial cardiometabolic burden in a small urban Argentine population and suggests that self-report-based national surveys may misestimate true DM prevalence. Laboratory-confirmed, community-based surveillance is essential to strengthen early detection, guide targeted interventions, and inform equitable public health strategies.

5 January 2024 in NeuroTarget
Verified
Journal Article
Open access
PDF file
FRFrancisco Rivera
Francisco Rivera
NCNelson Ernesto Quintanal Cordero
Nelson Ernesto Quintanal Cordero
RMRaisa Braña Miranda
Raisa Braña Miranda
FPFabián Piedimonte
Fabián Piedimonte
Background: Magnetic resonance-guided focused ultrasound (MRgFUS) has emerged as a minimally invasive alternative for treating motor complications in advanced Parkinson's disease (PD). This systematic review evaluates the efficacy, safety, and technical parameters of globus pallidus internus (GPi) pallidotomy using MRgFUS in PD patients.Methods: A systematic review was conducted following PRISMA guidelines, searching PubMed/MEDLINE, Embase, Scopus and Web of Science, through February 2024. Clinical studies evaluating MRgFUS-guided GPi pallidotomy in PD patients were included, with minimum follow-up of one month and at least 3 patients per study.Results: Four studies including 101 patients were analyzed. Eisenberg et al. reported 59% improvement in Unified Dyskinesia Rating Scale (UdysRS) scores at 3 months (p<0.0001), maintained at 12 months (43% improvement). Jung et al. demonstrated 52.7% UdysRS reduction at 6 months and 42.7% at 12 months. MDS-UPDRS III scores improved significantly in "off" medication state, with Eisenberg et al. showing 44.5% improvement at 3 months and 45.2% at 12 months. Krishna et al. found 69% response rate in active treatment group versus 32% in controls (p=0.003). Adverse events were generally mild and transitory, including transient dysarthria, fine motor deficits, and headache during sonication.Conclusions: MRgFUS GPi pallidotomy demonstrates significant and sustained efficacy in treating levodopa-induced dyskinesias and motor fluctuations in PD patients, with an acceptable safety profile. Technical parameters vary across studies, emphasizing the need for individualized treatment protocols. Further research is warranted to optimize patient selection and procedural standardization. Keywords: Parkinson's disease, MRgFUS, globus pallidus internus, pallidotomy, dyskinesias

1 January 2025 in NeuroTarget
Verified
Journal Article
Open access
PDF file
RMRaisa Braña Miranda
Raisa Braña Miranda
FRFrancisco Rivera
Francisco Rivera
NCNelson Ernesto Quintanal Cordero
Nelson Ernesto Quintanal Cordero
FPFabián Piedimonte
Fabián Piedimonte
​Introduction: Ventral intermediate nucleus (VIM) thalamotomy using magnetic resonance-guided focused ultrasound (MRgFUS) has emerged as a minimally invasive alternative for refractory parkinsonian tremor. This study evaluates the efficacy, safety, and technical parameters of this intervention in patients with Parkinson's disease.Methods: A systematic review was conducted following PRISMA guidelines. Clinical studies evaluating VIM-targeted MRgFUS in Parkinson's disease with minimum one-month follow-up were included. Clinical variables (tremor reduction via CRST and MDS-UPDRS III, adverse events), technical parameters (maximum temperature, number of sonications, stereotactic coordinates), and technological evolution were analyzed.Results: Eleven studies reported 97 treated patients. Significant MDS-UPDRS III reductions were observed: 12.88 points at 1 month, 12.10 at 3 months, 14.85 at 6 months, and 20.65 at 12 months in medication "on" state. Adverse effects were mostly transient, including headache, dizziness, gait disturbances, and paresthesias, with spontaneous resolution in most cases. Technical parameters varied between studies, with average coordinates of 6.90-9.08 mm anterior to PC and 13.11-14.93 mm lateral from midline.Discussion: MRgFUS demonstrates sustained efficacy for parkinsonian tremor control with favorable safety profile compared to deep brain stimulation. Technological advances have optimized precision and reduced complications. Variability in technical parameters reflects technological evolution and the need for individualized targeting.

1 January 2025 in NeuroTarget
Verified
Journal Article
Open access
PDF file
RMRaisa Braña Miranda
Raisa Braña Miranda
FRFrancisco Rivera
Francisco Rivera
NCNelson Ernesto Quintanal Cordero
Nelson Ernesto Quintanal Cordero
FPFabián Piedimonte
Fabián Piedimonte
Introducción: La enfermedad de Parkinson (EP) frecuentemente progresa hacia complicaciones motoras refractarias. Aunque la DBS-STN es altamente eficaz, su naturaleza invasiva limita su accesibilidad. El MRgFUS-STN ha emergido como alternativa no invasiva. Esta revisión sistemática evalúa la eficacia y seguridad de MRgFUS-STN en el manejo de la EP.Métodos: Revisión sistemática de estudios (2014-2024) siguiendo directrices PRISMA. Se consultaron las bases de datos PubMed, Embase y Cochrane Library. Estudios incluidos: ensayos aleatorizados, cohortes prospectivas y series de casos (n≥10) evaluando MRgFUS-STN. Resultados primarios: cambios en MDS-UPDRS III y perfiles de seguridad.Resultados: Veinte estudios (258 pacientes) cumplieron criterios de inclusión. El metaanálisis mostró reducciones significativas en MDS-UPDRS III en estados off-medicación (-13.8 puntos, IC 95%: -16.2 a -11.4, p<0.001). Un ensayo aleatorizado demostró 52.6% de mejoría versus 8% en controles (p<0.001). El análisis por componentes reveló 83.5% de mejoría en rigidez, 69.4% en bradicinesia y 91.5% en temblor. Los eventos adversos fueron leves y transitorios (disartria 20-25%, inestabilidad de marcha 25-41%) sin complicaciones permanentes.Conclusiones: MRgFUS-STN demuestra eficacia significativa y seguridad favorable para EP refractaria, con resultados comparables a DBS-STN, ofreciendo menor invasividad. Se requieren ensayos multicéntricos más amplios para directrices definitivas de implementación.

17 October 2025 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
FRFrancisco Rivera
Francisco Rivera
MCMatias Ignacio Cosimano
Matias Ignacio Cosimano
CECyrus Elahi
Cyrus Elahi
LLLuciano Lorenzini
Luciano Lorenzini
ABArnau Benet
Arnau Benet
CGClaudio Gonzalez
Claudio Gonzalez

20 February 2026 in World Neurosurgery
Verified
Journal Article
Open access
ABArnau Benet
Arnau Benet
CECyrus Elahi
Cyrus Elahi
FRFrancisco Rivera
Francisco Rivera
CBChristina Benet
Christina Benet
BLBruno Eduardo Díaz Llanes
Bruno Eduardo Díaz Llanes
MLMichael T Lawton
Michael T Lawton
To evaluate the number of operative neuroanatomy lectures and their impact on the academic and surgical excellence of neurosurgery trainees in Andean Latin America. A total of 132 residents and early-career neurosurgeons from Andean Latin America participated in this study. An electronic open-ended survey was distributed. Participants completed preintervention and postintervention surveys, and neuroanatomy knowledge was assessed before and after different educational interventions. Participants were grouped by access to lecture frequency (10 lectures) and format (virtual vs. in person). Comparisons were based on training location (e.g., capital, urban, rural) and residency training level or early-career stage. More than one-half (80 of 132, 61%) of participants reported that they had attended 10 lectures. Trainees with access to >10 lectures demonstrated higher proficiency levels, particularly in supratentorial anatomy (P < 0.01). In addition, learning outcomes did not differ by lecture format. Chief residents based in capital programs had more access to >5 lectures compared with their urban peers (24 of 29 [83%] and 2 of 9 [22%], respectively) (P < 0.01). These findings support virtual lectures as an effective and scalable approach to bridging gaps in neurosurgery education. Expanding free web-based resources that are tailored to the educational needs of neurosurgery residents in low- and middle-income countries could enhance training and improve workforce competency in underserved regions.